US Broker Ratings

Molina Healthcare Inc (MOH) Investor Outlook: Unpacking Growth Potential Amidst Market Volatility

As Molina Healthcare Inc (NYSE: MOH) navigates the intricacies of the healthcare sector, its current financial standing offers a compelling narrative for investors looking for growth potential. With a market..

Baxter International Inc. (BAX) Stock Analysis: Evaluating a 21.63% Upside Potential in the Healthcare Sector

Baxter International Inc. (BAX), a key player in the healthcare sector, offers a compelling investment opportunity with a potential upside of 21.63%. The company, headquartered in Deerfield, Illinois, operates within..

Qiagen N.V. (QGEN) Investor Outlook: Analyzing the 4.71% Potential Upside in the Diagnostics & Research Sector

For investors exploring opportunities in the healthcare sector, Qiagen N.V. (NASDAQ: QGEN) presents a compelling case, particularly in the diagnostics and research industry. Headquartered in Venlo, the Netherlands, Qiagen is..

Biogen Inc. (BIIB) Stock Analysis: Exploring a 15% Potential Upside Amidst Robust Neurological Pipeline

Biogen Inc. (NASDAQ: BIIB), a titan in the healthcare sector, stands at a pivotal juncture with a market capitalization of $21.98 billion. Specializing in neurological and neurodegenerative therapies, Biogen has..

STERIS plc (STE) Stock Analysis: A 13% Upside Beckons for Healthcare Investors

For investors eyeing the healthcare sector, STERIS plc (NYSE: STE) presents a compelling opportunity with a potential upside of 13.13% based on current analyst price targets. With a market capitalization..

ICON plc (ICLR) Investor Outlook: Analyzing a Strong 17% Upside Potential

For investors with a keen eye on the healthcare sector, ICON plc (NASDAQ: ICLR) offers a compelling opportunity. Based in Dublin, Ireland, ICON plc is a global leader in diagnostics..

BeOne Medicines Ltd. (ONC) Investor Outlook: Strong Buy Ratings and a Promising 23.13% Upside Potential

BeOne Medicines Ltd. (ONC), a major player in the biotechnology sector, is rapidly making its mark with a robust pipeline of oncology treatments. Based in Switzerland, this company, formerly known..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring a 13% Upside Potential in the Biotech Sector

Exelixis, Inc. (NASDAQ: EXEL) stands out in the biotech sector, not only due to its innovative cancer treatments but also because of its current market performance and potential upside. With..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating Healthcare’s Investment Landscape with a 6.83% Upside

As the healthcare sector continues to be a focal point for investors seeking stability and growth, Universal Health Services, Inc. (NYSE: UHS) stands out with its robust financial performance and..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Healthcare Sector Dynamics with Strategic Insights

Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, continues to be a focal point for investors looking to capitalize on the evolving landscape of medical instruments and..

Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Leader with 14% Potential Upside

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector specializing in diagnostics and research, offers an intriguing opportunity for investors seeking exposure to a company with a rich..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A Look at Its 7.45% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $20.41 billion, the company..

Danaher Corporation (DHR) Stock Analysis: Strong Buy Ratings Signal Promising 14% Upside

Danaher Corporation (NYSE: DHR) stands as a formidable entity in the healthcare sector, primarily operating within the diagnostics and research industry. With a commanding market capitalization of $157.52 billion, Danaher..

IDEXX Laboratories (IDXX) Stock Analysis: Strong Revenue Growth and Strategic Market Position

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $51.27 billion, the company’s..

Novartis AG (NVS): Investor Outlook on a Healthcare Giant with a 3.06% Dividend Yield

Novartis AG (NYSE: NVS), a behemoth in the global healthcare sector, continues to capture investor attention with its robust market position and substantial dividend yield. As a leading player in..

Genmab A/S (GMAB) Stock Analysis: Strong Growth and 25.84% Upside Potential Captivate Investors

Genmab A/S (GMAB), a prominent player in the biotechnology sector, stands out on the global stage with a market capitalization of $18.4 billion. Based in Denmark, Genmab specializes in developing..

argenx SE (ARGX) Stock Analysis: Strong Buy Ratings Propel Growth Prospects

argenx SE (ARGX), a dynamic player in the biotechnology sector, has captured the attention of the investment community with its impressive growth trajectory and robust analyst support. Based in the..

McKesson Corporation (MCK) Stock Analysis: Navigating Growth and Opportunities in the Healthcare Sector

Investors keeping an eye on the healthcare sector might find McKesson Corporation (NYSE: MCK) an intriguing prospect. With a market capitalization of $99.72 billion, McKesson stands as a formidable player..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare Growth with a 5.66% Upside

Centene Corporation (NYSE: CNC) stands out in the healthcare sector as a major player in the healthcare plans industry. With a market capitalization of $16.73 billion, Centene offers a robust..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a 50.71% Potential Upside Amidst Biotech Challenges

Moderna, Inc. (NASDAQ: MRNA) has become a household name, primarily due to its groundbreaking work in mRNA vaccines, most notably its COVID-19 vaccine. However, the company’s financial journey presents a..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds